What I can't wait to see are BETonMACE trial news releases like they did for ASSURE in 2011. It took ~5 months between the "Launching" June 13th news release to the "Commences Dosing" November 2nd news release. If history repeats itself for BETonMACE in 2015, we may see BETonMACE "Launch" announcment sometime after the June 30th special meeting and "Commences Dosing" announcement in Q4 2015, which would still be consistent with the H2 2015 estimates that we've been hearing. But I wouldn't get my hopes up for dosing to start anytime soon without seeing any official news releases yet.

June 13, 2011: Resverlogix Launches Phase IIb ASSURE Trial for RVX-208 Cholesterol Transport Drug, Safety Data Completed and Filed

September 26, 2011: Resverlogix Activates Study Sites in ASSURE Phase 2b IVUS Trial for Atherosclerotic Plaque Regression

November 2, 2011: Resverlogix Commences Dosing in ASSURE a Phase 2b IVUS Clinical Trial Targeting High-Risk Cardiovascular Disease Patients